ETFsS&P MidCap 400 ® Index
State Street / SPDR
State Street® SPDR® S&P® 400 U.S. Mid Cap UCITS ETF (Acc)
SPY4 XETRAAccumulatingPhysical, full replicationIrelandNot PEA-eligible
Last close · EUR
101.04EUR
-1.58% · -€1.62
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
SPY4Base
- Fund charges
- 0.30%PRIIPs ongoing costs
- Fund size
- €5.1bnall share classes
- Return 1Y
- +16.1%
- Sharpe 3Y
- 0.68
- Volatility 1Y
- 12.7%annualised
- Holdings
- 400Fund holdings
Performance
Compare
- SPY4+16.1%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| SPY4 | -1.3% | -2.8% | +4.2% | +14.3% | +16.1% | +44.1% | +35.3% |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.0% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | +1.5% | -2.2% | -3.6% | +0.3% | +2.0% | -21.5% | -29.5% |
Risk and return
Sharpe ratio · 3Y
0.68
Below MSCI World · 1.24- Return p.a.
- +13.4%
- Volatility
- 16.4%
- Max loss
- -29.1%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
SPY4
0.68
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 6.7%
- Holdings
- 400
- As of
- 1United Therapeutics CorporationUS91307C10270.75%
- 2TechnipFMC plcGB00BDSFG9820.73%
- 3ATI IncUS01741R10230.70%
- 4US Foods Holding Corp.US91200810990.69%
- 5Tenet Healthcare CorporationUS88033G40730.68%
- 6Reliance Inc.US75950910230.65%
- 7XPO Inc.US98379310080.64%
- 8Entegris Inc.US29362U10430.63%
- 9Roku Inc. Class AUS77543R10230.62%
- 10Royal Gold Inc.US78028710840.60%
Countries
Classified 100.0%
United States99.5%
- Largest
- 99.5%United States
- Top 3
- 100.0%
- Effective number
- 1.01 / HHI
Market cap
Weight vs holdings
6.7%of the fund sits in the top 10 holdings
19.2%44.7%29.4%
WeightHoldings
40150200
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
